Can a damaged kidney change how antibiotics work?

NCT ID NCT07758608

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial is investigating how different levels of kidney function affect the way the body processes a single dose of the antibiotic afabicin. About 60 adults with varying degrees of kidney impairment, from mild to severe, will receive either an oral tablet or an intravenous infusion of the drug. Researchers will measure drug levels in the blood over time to see if kidney function alters how the drug is absorbed and cleared. The goal is to understand whether dose adjustments are needed for people with kidney problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
afabicin (oral or intravenous)
What this could lead to
If successful, this could help determine the right afabicin dose for people with kidney problems, making the antibiotic safer and more effective for them.
What could go wrong
This is an early-stage trial with a single dose, so results may not reflect real-world use. Kidney impairment may alter drug levels in unexpected ways, and the study is not designed to test how well the drug works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.